Clinical Trial Update: Letrozole in Breast Cancer Who Have Received 5 Years of Aromatase Inhibitor Therapy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating letrozole in breast cancer patients who have already received five years of aromatase inhibitor therapy has been completed w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Letrozole (letrozole)

Snippet

Sponsor: Canadian Cancer Trials Group | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2018-11-19